Noga Shem‐Tov

CXCR4 Regulates Migration and Development of Human Acute Myelogenous Leukemia Stem Cells in Transplanted NOD/SCID Mice

Sigal Tavor, Isabelle Petit, Svetlana Porozov et al. · Cancer Research · 2004 · 352 citations · Full text

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity

Avichai Shimoni, Izhar Hardan, Noga Shem‐Tov et al. · Leukemia · 2005 · 311 citations

Cell Therapy, Transplantation, Marrow Transplantation +9

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan

Avichai Shimoni, Izhar Hardan, Noga Shem‐Tov et al. · Leukemia · 2007 · 106 citations

Non-relapse Mortality, Transplantation, Marrow Transplantation +10

Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma

Abraham Avigdor, Shlomo Bulvik, I. Levi et al. · Annals of Oncology · 2009 · 100 citations · Full text

Lymphoid Neoplasia, Surgical Oncology, Escalated Beacopp +9

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning

Avichai Shimoni, Nicolaus Kröger, Tatjana Zabelina et al. · Leukemia · 2004 · 99 citations

Unrelated Donors, Transplantation, Marrow Transplantation +11